Unraveling the genetic component of systemic sclerosis

Hum Genet. 2012 Jul;131(7):1023-37. doi: 10.1007/s00439-011-1137-z. Epub 2012 Jan 5.

Abstract

Systemic sclerosis (SSc) is a severe connective tissue disorder characterized by extensive fibrosis, vascular damage, and autoimmune events. During the last years, the number of genetic markers convincingly associated with SSc has exponentially increased. In this report, we aim to offer an updated review of the classical and novel genetic associations with SSc, analyzing the firmest and replicated signals within HLA and non-HLA genes, identified by both candidate gene and genome-wide association (GWA) studies. We will also provide an insight into the future perspectives and approaches that might shed more light into the complex genetic background underlying SSc. In spite of the remarkable advance in the field of SSc genetics during the last decade, the use of the new genetic technologies such as next generation sequencing (NGS), as well as the deep phenotyping of the study cohorts, to fully characterize the genetic component of this disease is imperative.

Publication types

  • Review

MeSH terms

  • Autoantibodies / immunology
  • Autoimmune Diseases / genetics
  • Genetic Markers*
  • Genetic Predisposition to Disease*
  • Genetic Variation
  • Genome-Wide Association Study
  • HLA Antigens / genetics
  • Humans
  • Scleroderma, Systemic / genetics*
  • Scleroderma, Systemic / immunology

Substances

  • Autoantibodies
  • Genetic Markers
  • HLA Antigens